Antidepressant Medication Is The Fastest Growing Segment Fueling The Growth Of Major Depressive Disorder Treatment Market
Major Depressive Disorder Treatment Market Major Depressive Disorder (MDD) also known as clinical depression or unipolar depression, is a mood disorder that causes disturbing and prolonged feelings of sadness, worthlessness or emptiness. Treatment options for MDD include counseling, psychotherapy and antidepressant medication. The global Major Depressive Disorder Treatment Market is estimated to be valued at US$ 11.83 Bn in 2023 and is expected to exhibit a CAGR of 2.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key trends in the MDD treatment market is the increasing utilization of pharmacogenetic testing along with antidepressant treatment. Pharmacogenetic testing examines how a person's genes affect their body's response to antidepressant medications. By identifying gene variations that influence medication metabolism and activity, pharmacogenetic testing helps physicians sele...